Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B

Yang, JG; Liu, YC; He, AB; Liu, YH; Wu, JT; Liao, XH; Lv, ZJ; Wang, F; Mei, HB

Mei, HB (reprint author), Guangzhou Med Univ, Shenzhen Peoples Hosp 2, Dept Urol, Clin Inst, Shenzhen, Peoples R China.; Mei, HB (reprint author), Shenzhen Univ, Shenzhen Peoples Hosp 2, Key Lab Med Reprogramming Technol, Affiliated Hosp 1, Shenzhen, Peop

ONCOTARGET, 2017; 8 (40): 68721

Abstract

Background and Objectives: Hsa-miR-429 is increased in bladder cancer. Its roles in bladder cancer are poorly understood. Methods: The expression leve......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索